(AUSTIN) — The Cancer Prevention and Research Institute of Texas (CPRIT) today awarded new grants totaling over $56 million and consisting of 13 academic research recruitment awards and a product development research award.
News & Events
Due to circumstances beyond our control, CPRIT has made the difficult decision to cancel the upcoming Innovations in Cancer Prevention and Research Conference VI scheduled for July 30 – 31, 2020.
Texas continues to operate under state and local orders that prohibit gatherings and restrict travel due to the COVID-19 pandemic. With no indication that authorities will lift these orders soon, this uncertainty makes it impossible for conference speakers and attendees to schedule travel, book accommodations, or submit scholarly content for the conference.
(AUSTIN) — The Cancer Prevention and Research Institute of Texas (CPRIT) today awarded 55 new grants totaling over $78 million consisting of 41 academic research grant awards, 10 prevention awards, and 4 product development research awards.
“These awards reflect CPRIT's established priorities to invest in childhood cancer research, address population and geographic disparities, and recruit top cancer research talent to our academic institutions,” said Wayne Roberts, CPRIT Chief Executive Officer. “I'm excited about all the awardees, particularly those in San Antonio, a region that continues expand their cancer research and prevention prowess. San Antonio is poised to have an even greater impact across the Texas cancer-fighting ecosystem.”
Addressing childhood cancer is a top priority for CPRIT with 12 percent of our portfolio going to pediatric cancer research, which is proportionately three times more than the national rate. Earlier this month in Dallas, the Carson Leslie Foundation and CPRIT gathered the best minds in pediatric brain cancer research to chart ways forward for increasing collaboration.
(AUSTIN) — The Cancer Prevention and Research Institute of Texas (CPRIT) announced the recruitment of its 200th CPRIT Scholar to Texas. Theresa Guise, M.D., a leading physician scientist in the study of skeletal complications of cancer, including bone metastasis, bone loss and muscle weakness has accepted a CPRIT Established Investigator Award to join The University of Texas MD Anderson Cancer Center from Indiana University School of Medicine.
"CPRIT Scholars have bolstered the life sciences ecosystem in Texas, bringing talented individuals and their scientific knowledge to build a critical mass in the fight against cancer,” said Dr. James Willson, CPRIT Chief Scientific Officer. “I welcome Dr. Guise to Texas, and she joins a long line of researchers who have grounded themselves here and continue to provide invaluable contributions for better understanding the science behind cancer and how it can be successfully treated."
CPRIT has invested more than $2.4 billion in cancer research and prevention across the state, positioning CPRIT as the second largest source of public funding.